MSLE
Price
$8.50
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
186.67M
Intraday BUY SELL Signals
RVMD
Price
$206.71
Change
+$0.82 (+0.40%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
43.24B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MSLE vs RVMD

MSLE vs RVMD Comparison Chart in %
View a ticker or compare two or three
VS
MSLE vs. RVMD commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSLE is a Hold and RVMD is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
MSLE vs RVMD: Fundamental Ratings
MSLE
RVMD
OUTLOOK RATING
1..100
5528
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
1002
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
20100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MSLE's Valuation (47) in the null industry is somewhat better than the same rating for RVMD (95). This means that MSLE’s stock grew somewhat faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (2) in the null industry is significantly better than the same rating for MSLE (100). This means that RVMD’s stock grew significantly faster than MSLE’s over the last 12 months.

RVMD's SMR Rating (98) in the null industry is in the same range as MSLE (98). This means that RVMD’s stock grew similarly to MSLE’s over the last 12 months.

RVMD's Price Growth Rating (34) in the null industry is in the same range as MSLE (34). This means that RVMD’s stock grew similarly to MSLE’s over the last 12 months.

MSLE's P/E Growth Rating (20) in the null industry is significantly better than the same rating for RVMD (100). This means that MSLE’s stock grew significantly faster than RVMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MSLERVMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 17 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (MSLE: $8.50 vs. RVMD: $205.89)
Brand notoriety: MSLE and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSLE: 182% vs. RVMD: 90%
Market capitalization -- MSLE: $186.67M vs. RVMD: $43.24B
MSLE [@Biotechnology] is valued at $186.67M. RVMD’s [@Biotechnology] market capitalization is $43.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSLE’s FA Score shows that 1 FA rating(s) are green while RVMD’s FA Score has 1 green FA rating(s).

  • MSLE’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, MSLE is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSLE’s TA Score shows that 3 TA indicator(s) are bullish while RVMD’s TA Score has 6 bullish TA indicator(s).

  • MSLE’s TA Score: 3 bullish, 5 bearish.
  • RVMD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than MSLE.

Price Growth

MSLE (@Biotechnology) experienced а -2.41% price change this week, while RVMD (@Biotechnology) price change was +3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

RVMD is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MSLE
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FIGG16.200.81
+5.26%
Leverage Shares 2x Long FIG Daily ETF (FIGG)
PSFF35.190.08
+0.23%
Pacer Swan SOS Fund of Funds ETF (PSFF)
DLN97.260.06
+0.06%
WisdomTree U.S. LargeCap Dividend Fund (DLN)
CHGX33.05N/A
N/A
EA SERIES TRUST STANCE SUSTAINABLE BETA ETF
INDL38.98-0.53
-1.34%
Direxion Daily MSCI India Bull 2X ETF (INDL)

MSLE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSLE
1D Price
Change %
MSLE100%
N/A
ANL - MSLE
40%
Loosely correlated
-1.50%
RVMD - MSLE
27%
Poorly correlated
+0.31%
BNTX - MSLE
26%
Poorly correlated
-1.48%
ACHV - MSLE
25%
Poorly correlated
-6.92%
IPSC - MSLE
23%
Poorly correlated
-5.85%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with GLUE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.31%
GLUE - RVMD
42%
Loosely correlated
-5.62%
ARRY - RVMD
39%
Loosely correlated
-3.47%
AXON - RVMD
39%
Loosely correlated
-0.07%
REPL - RVMD
38%
Loosely correlated
+1.59%
AMRN - RVMD
38%
Loosely correlated
-2.15%
More